Camlin Fine Sciences · NSE: CAMLINFINE · BSE: 532834

Q1 FY24 results · Apr–Jun 2023

Camlin Fine Sciences reported revenue from operations of ₹419.60 crore (up 9.3% from Q1 FY23) and net profit of ₹12.02 crore (up 233.9% from Q1 FY23) for Q1 FY24 (Apr–Jun 2023), on a consolidated basis.

Consolidated · ₹ crore
ItemQ1 FY24Q1 FY23YoYQ4 FY23QoQ
Revenue from operations419.60383.77+9.3%426.71−1.7%
Other income6.371.03+520.8%2.00+219.0%
Total income425.97384.80+10.7%428.70−0.6%
Profit before tax16.0814.55+10.5%8.43+90.8%
Net profit for the period12.023.60+233.9%3.48+245.4%
Attributable to shareholders of the company15.555.89+164.2%9.16+69.8%
EPS, basic (₹)0.960.37+159.5%0.59+62.7%
Net margin (%)2.90.90.8
Standalone · ₹ crore
ItemQ1 FY24Q1 FY23YoYQ4 FY23QoQ
Revenue from operations161.11155.44+3.6%218.16−26.1%
Other income6.0112.74−52.8%1.24+385.5%
Total income167.12168.17−0.6%219.40−23.8%
Profit before tax7.265.16+40.8%11.44−36.5%
Net profit for the period5.785.27+9.6%7.80−25.9%
EPS, basic (₹)0.360.34+5.9%0.51−29.4%
Net margin (%)3.63.43.6
Consolidated
Filed with BSE
11 Aug 2023, 17:37 IST
Board meeting
11 Aug 2023
Period
01 Apr 2023 to 30 Jun 2023
Review status
Unaudited
Source
XBRL filing on BSE
Standalone
Filed with BSE
11 Aug 2023, 17:37 IST
Board meeting
11 Aug 2023
Period
01 Apr 2023 to 30 Jun 2023
Review status
Unaudited
Source
XBRL filing on BSE